ASTRO 2019 to Feature Clinical Experience and Patient Outcomes With Viewray MRIdian

UF startup ViewRay, Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the company’s MRIdian and MRIdian Linac magnetic resonance imaging (MRI)-guided radiation therapy systems will be featured at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO). The meeting will feature a number of presentations highlighting the capabilities, clinical experience and patient outcomes with ViewRay’s MRIdian and MRIdian Linac.